Michael Baker
Vermogen: 344 895 $ op 31-07-2026
Vermogen: 344 895 $ op 31-07-2026
Michael Baker is currently Director at Radiopharm Theranostics (USA), Inc. and Investment Associate at Bioscience Managers Pty Ltd. Former roles include Chief Executive Officer, MD & Director at Arovella Therapeutics Ltd. from 2021 to 2026, Independent Non-Executive Director at Radiopharm Theranostics Ltd. from 2021 to 2024, and Senior Manager at Hexima Ltd. Education includes an MBA from Melbourne Business School and undergraduate and graduate degrees from La Trobe University, conferred in 2004 and 2009 respectively.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-05-2026 | 8.184.493 ( 0,68% ) | 344 895 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Analist | 01-11-2017 |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Algemeen Directeur | 04-05-2026 |
| RADIOPHARM THERANOSTICS LIMITED | Directeur/Bestuurslid | 26-03-2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Melbourne Business School
Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau